Epidural anesthesia, also known as regional anesthesia or epidurals, is administered through the intravenous route to block pain signals of a particular region of the body. The aim of epidural anesthesia is to impart an analgesic effect, leading to complete absence of sensation in that part of the body. The epidural anesthesia generally blocks pain signals from the lower spine, decreasing the sensation in lower half of the body. The epidural consists of analgesic medications such as lidocaine and chloroprocaine. They are often combined with the local opioids to decrease the dose of the local anesthesia. Key players operating in the epidural anesthesia market have introduced sets and kits of regional anesthesia, providing a customized range of doses, depending on clinical requirements of the patient. Customized and self-procedure kits of anesthesia contain components required for single-dose or continuous delivery of anesthesia.
Upsurge in the number of surgeries across the globe and preference for epidurals by pregnant women due to their ease of use and reliability are major factors driving the market for epidural anesthesia sets. However, a few side-effects associated with the epidural anesthesia in pregnant women such as prolonged labor pain and maternal exhaustion after delivery are expected to restrain the market during the forecast period.
The global epidural anesthesia sets market can be segmented based on type and end-user. Based on type, the market has been segmented into regular epidural sets and Combined Spinal-Epidural (CSE). The regular epidural sets segment accounted for the maximum market share in terms of value in 2016, which is attributable to rise in the number of surgical procedures and increase in elderly population across the globe. However, the CSE segment is projected to dominate the global epidural anesthesia sets market during the forecast period, due to availability of well-qualified anesthesiologists that are trained in the delivery of spinal epidurals in developed countries and numerous awareness campaigns being conducted by governments of these countries. Introduction of a wide variety of spinal epidural sets by key players in the market, developed for the delivery of single dose as well as continuous dose of anesthesia is projected to boost the CSE segment between 2017 and 2025. Based on end-user, the global epidural anesthesia sets market has been segmented into hospitals, clinics, ambulatory surgical centers, and home care settings. The hospitals segment dominated the epidural anesthesia sets market in 2016, owing to the rising per capita health care expenditure in developing countries and preference by pregnant women for epidural anesthesia during the delivery. The home care settings segment is estimated to expand at the maximum CAGR from 2017 to 2025. This is attributable to the availability of optimized and customized line of epidural trays and sets. Increased number of hospitals across the globe and efficient distribution of epidural sets by key manufacturers led by favorable international trade policies are factors driving the hospitals segment.
Geographically, the global epidural anesthesia sets market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2016, North America accounted for the maximum market share in terms of value, owing to the rising adoption of epidural anesthesia sets by patients and physicians in the region. Epidural anesthesia sets make physicians capable of altering the anesthesia dosage as per their clinical requirements. Moreover, the market in Asia Pacific is anticipated to register the maximum CAGR during the forecast period, due to improved infrastructure of hospitals and other health care centers in the region and investments by public and private players in the health care sector in countries of Asia.
Some of the prominent players operating in the global epidural anesthesia sets market are B. Braun Medical Inc., VOGT MEDICAL, Baxter, Hull Anesthesia, Suru International Private Limited, Becton, Dickinson and Company, Smiths Medical, Teleflex Incorporated, Halyard Health, Inc., and Kimberly-Clark Corporation.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.